A PP2A molecular glue overcomes RAS/MAPK inhibitor resistance in KRAS-mutant non-small cell lung cancer. - Raines B; Tseng-Rogenski S; Dowdican AC; Peris I; Hinderman M; Zawacki KP; Barrie K; Hodges Onishi G; Dymond AM; Luther TK; Musser S; Karaj Majchrowski B; et al. (The Journal of clinical investigation, 2025)